Postoperative recurrence patterns and anatomy-stratified clinical target volume delineation in pancreatic cancer.
[OBJECTIVES] This study aims to characterize postoperative recurrence patterns and anatomical distribution in patients with pancreatic cancer within the framework of extrapancreatic neural tract anato
APA
Ge Y, Leng B, et al. (2026). Postoperative recurrence patterns and anatomy-stratified clinical target volume delineation in pancreatic cancer.. Radiation oncology (London, England), 21(1), 26. https://doi.org/10.1186/s13014-026-02786-0
MLA
Ge Y, et al.. "Postoperative recurrence patterns and anatomy-stratified clinical target volume delineation in pancreatic cancer.." Radiation oncology (London, England), vol. 21, no. 1, 2026, pp. 26.
PMID
41520105
Abstract
[OBJECTIVES] This study aims to characterize postoperative recurrence patterns and anatomical distribution in patients with pancreatic cancer within the framework of extrapancreatic neural tract anatomy. Based on the observed recurrence sites, we propose stratified clinical target volume (CTV) delineation recommendations for postoperative adjuvant radiotherapy.
[METHODS] We retrospectively analysed 352 patients who underwent resection for pancreatic adenocarcinoma and recorded the sites of initial postoperative recurrence. Recurrence foci were reconstructed according to adjacent anatomical structures and mapped onto reference computed tomography images of the pancreatic head and of the body/tail. Spatial distances and distribution relative to major vessels were measured to define vessel-anchored CTV extension ranges for different primary tumour locations. These ranges were compared with the delineation recommendations of RTOG 0848 and the NRG consensus guidelines.
[RESULTS] Recurrence occurred in 285 patients (81%), with 187 head tumours and 98 body/tail tumours. Regional failures clustered along a limited number of extrapancreatic plexus pathways. In both head and body/tail tumours, more than four fifths of plexus-related recurrences arose along a pancreatic head plexus II (PLph II)/ superior mesenteric artery (SMA) plexus (PLsma)–celiac axis (CA) plexus (PLce) continuum centred on the axis between the SMA and CA, with a periaortic neurovascular corridor representing the caudal extension of this pathway. We propose a CTV strategy comprising a 0.7 cm margin around the CA, an approximately 1.0 cm margin around the portal vein (PV), common hepatic artery (CHA) and SMA, and an asymmetric periaortic expansion with 1.5 cm anteriorly and to the right, 1.0 cm to the left, and the posterior border confined to the anterior vertebral margin. For pancreatic head tumours, these margins are integrated into a CTV-based “Triangle Volume (TV)” that extends from the PV/CHA–SMA–CA triangle back to the periaortic corridor. For body and tail tumours, the CTV prioritises coverage of the CA–SMA–proximal periaortic neurovascular corridor while avoiding routine inclusion of the distal splenic artery and splenic hilum.
[CONCLUSIONS] Vessel-anchored mapping validates the TV framework for pancreatic head tumours and provides quantitative, anatomy-stratified CTV recommendations for pancreatic head and body/tail primaries in the adjuvant setting.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s13014-026-02786-0.
[METHODS] We retrospectively analysed 352 patients who underwent resection for pancreatic adenocarcinoma and recorded the sites of initial postoperative recurrence. Recurrence foci were reconstructed according to adjacent anatomical structures and mapped onto reference computed tomography images of the pancreatic head and of the body/tail. Spatial distances and distribution relative to major vessels were measured to define vessel-anchored CTV extension ranges for different primary tumour locations. These ranges were compared with the delineation recommendations of RTOG 0848 and the NRG consensus guidelines.
[RESULTS] Recurrence occurred in 285 patients (81%), with 187 head tumours and 98 body/tail tumours. Regional failures clustered along a limited number of extrapancreatic plexus pathways. In both head and body/tail tumours, more than four fifths of plexus-related recurrences arose along a pancreatic head plexus II (PLph II)/ superior mesenteric artery (SMA) plexus (PLsma)–celiac axis (CA) plexus (PLce) continuum centred on the axis between the SMA and CA, with a periaortic neurovascular corridor representing the caudal extension of this pathway. We propose a CTV strategy comprising a 0.7 cm margin around the CA, an approximately 1.0 cm margin around the portal vein (PV), common hepatic artery (CHA) and SMA, and an asymmetric periaortic expansion with 1.5 cm anteriorly and to the right, 1.0 cm to the left, and the posterior border confined to the anterior vertebral margin. For pancreatic head tumours, these margins are integrated into a CTV-based “Triangle Volume (TV)” that extends from the PV/CHA–SMA–CA triangle back to the periaortic corridor. For body and tail tumours, the CTV prioritises coverage of the CA–SMA–proximal periaortic neurovascular corridor while avoiding routine inclusion of the distal splenic artery and splenic hilum.
[CONCLUSIONS] Vessel-anchored mapping validates the TV framework for pancreatic head tumours and provides quantitative, anatomy-stratified CTV recommendations for pancreatic head and body/tail primaries in the adjuvant setting.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s13014-026-02786-0.
같은 제1저자의 인용 많은 논문 (5)
- The Burden and Risk Factors of Colorectal Cancer in Older Adults From 2010 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021.
- RT-ICI therapy induces a distal immunometabolic axis that shapes systemic macrophage polarization and enhances local T cell immunity.
- KSR2 functions as a metabolic checkpoint for anti-PD-1 resistance by reprogramming glucose metabolism.
- Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression.
- Proteomic and Transcriptomic Analyses Define Molecular Subtypes, Identify Biomarkers, and Suggest Potential Therapeutic Agent for Early-Stage HBV-Related Hepatocellular Carcinoma.